Puma Biotechnology Inc (PBYI)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -112.056 | -139.586 | -53.491 | -30.604 | -25.044 | -12.373 | 0.001 | 9.541 |
Return on Equity (%) | -132.752 | -221.913 | -259.28 | -292.047 | -1042.304 | 693.724 | 0.021 | 57.538 |
Return on Invested Capital (%) | -141.569 | -197.696 | -66.277 | -24.74 | -27.143 | 11.114 | 30.467 | 35.949 |
Operating Margin (%) | N/A | -1051.96 | -40.874 | -22.249 | -20.32 | -6.318 | 5.284 | 15.279 |
Net Profit Margin (%) | N/A | -1054.56 | -45.251 | -27.766 | -26.651 | -11.505 | 0.001 | 9.163 |
Book Value Per Share | 5.698 | 0.132 | -0.264 | -0.587 | -1.998 | -1.665 | -1.057 | -0.156 |
Earnings Per Share | -7.495 | -7.766 | -2.963 | -1.928 | -1.497 | -0.707 | N/A | 0.454 |
Cash Per Share | 5.281 | 2.173 | 2.829 | 1.531 | 2.128 | 1.533 | 1.644 | 1.778 |
Working Capital Per Share | 5.404 | 1.278 | 3.546 | 1.925 | 0.795 | 0.739 | 1.225 | 1.194 |
Operating Profit Per Share | N/A | 0.663 | 5.838 | 6.128 | 4.813 | 4.812 | 3.917 | 3.848 |
EBIT Per Share | -7.495 | -7.766 | -2.963 | -1.928 | -1.491 | -0.699 | 0.01 | 0.477 |
EBITDA Per Share | -7.495 | -7.766 | -2.963 | -1.928 | -1.491 | -0.699 | 0.01 | 0.477 |
Free Cash Flow Per Share | -7.328 | -6.499 | -3.14 | -2.043 | -1.176 | -0.919 | -0.034 | 0.507 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 36,83M | 37,6M | 38,33M | 39,2M | 40,09M | 41,18M | 46,35M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 45,61M | 46,35M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | 9.209 | N/A | N/A | N/A | -2.824 | N/A |
Net Profit Margin (%) | N/A | N/A | 2.655 | N/A | N/A | N/A | -11.002 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 143,34M |
Ratio cours/bénéfice | 6,64 |
Ratio prix/ventes | 0,61 |
Ratio prix/liquidités | 1,69 |
Ratio prix/valeur comptable | 2,68 |
Rendement de dividende | - |
Actions en circulation | 49,09M |
Volume moyen (1 semaine) | 504,29k |
Volume moyen (1 mois) | 496,67k |
Variation sur 52 semaines | -21,93% |
Plus haut sur 52 semaines | 7,73 |
Plus bas sur 52 semaines | 2,225 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales